Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000224838 | SCV000280713 | likely benign | not provided | 2015-10-07 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Labcorp Genetics |
RCV001082931 | SCV000652281 | benign | Neonatal-onset encephalopathy with rigidity and seizures | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000224838 | SCV000780877 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | BRAT1: BP4, BS2 |
Athena Diagnostics | RCV000224838 | SCV000841053 | benign | not provided | 2019-06-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000224838 | SCV001870022 | benign | not provided | 2018-08-29 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002500744 | SCV002805994 | likely benign | Neonatal-onset encephalopathy with rigidity and seizures; Neurodevelopmental disorder with cerebellar atrophy and with or without seizures | 2021-10-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002519755 | SCV003756162 | likely benign | Inborn genetic diseases | 2021-10-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV000224838 | SCV005228338 | likely benign | not provided | criteria provided, single submitter | not provided |